Low-Dose Weekly vs High-Dose Cisplatin

Abroad (travel likely)Recruiting

Conditions

Locally Advanced Head and Neck Squamous Cell Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Juravinski Cancer Centre, Hamilton, Ontario, Canada
Contact: Study coordinator (Brandon Meyers, MD) · meyersbr@hhsc.ca · 905-521-2100
London Regional Cancer Program, London, Ontario, Canada
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Contact: Study coordinator (Martin Smoragiewicz, MD) · martin.smoragiewicz@sunnybrook.ca · 416-480-4617

Study leads

Sara Kuruvilla, MD
Principal Investigator
London Health Sciences Centre, London Regional Cancer Program

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck Cancer

Head and Neck Cancer · Head Cancer · Head Cancer Neck

Abroad (travel likely)RecruitingPHASE1

Basking Ridge, United States · Middletown, United States

PDT For Induction Therapy For Head And Neck Cancer

Squamous Cell Carcinoma · Head and Neck Cancer Squamous Cell Carcinoma · Head and Neck Cancer

Abroad (travel likely)RecruitingPHASE2

Boston, United States · Boston, United States

Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

Squamous Cell Carcinoma

Abroad (travel likely)RecruitingPHASE2

Pittsburgh, United States

Becotatug Vedotin (MRG003) in Combination With PD-1 Inhibitor Versus PD-1 Inhibitor for the Treatment of EGFR-positive, CPS≥1 Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

Locally Advanced Head and Neck Squamous Cell Carcinoma

Abroad (travel likely)RecruitingPHASE3

Zhuhai, China